“…Approximately 30 studies have reported on associations between vitamin D pathway genotypes and risk of prostate cancer (9,13,15,16,21,24,26,27,29,51,53,56,57,62,65,68,70,73,78,83,84,88,89,91,98,99,101,115,128,130) (Supplemental Table 3). A meta-analysis of 14 studies published by Ntais et al (98) in 2003 concluded that four common polymorphisms (BsmI, TaqI, Poly(A) repeat, and FokI) in VDR are unlikely to be major determinants of prostate cancer susceptibility on a population-wide basis.…”